Target Validation Information
Target ID T84316
Target Name Voltage-dependent calcium channel subunit alpha-2/delta-1
Target Type
Successful
Drug Potency against Target (S)-2-amino-2-p-tolylacetic acid Drug Info Ki = 4900 nM [527946]
2-(1-(aminomethyl)-3-ethylcyclopentyl)acetic acid Drug Info IC50 = 55 nM [530504]
Gababutin Drug Info IC50 = 420 nM [530504]
N'-Acridin-9-yl-N,N-diethyl-butane-1,4-diamine Drug Info IC50 = 13000 nM [527016]
N,4-dibenzhydrylpiperazine-1-carboxamide Drug Info IC50 = 150 nM [530438]
1-benzhydryl-4-(3,3-diphenylpropyl)piperazine Drug Info IC50 = 5000 nM [530438]
(S)-2-amino-2-o-tolylacetic acid Drug Info Ki = 890 nM [527946]
(R)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid Drug Info IC50 = 1460 nM [527684]
3-(aminomethyl)-4-(furan-3-yl)butanoic acid Drug Info IC50 = 518 nM [527684]
2-(1-(aminomethyl)-3-butylcyclopentyl)acetic acid Drug Info IC50 = 690 nM [530504]
3-Aminomethyl-5-methyl-hexanoic acid Drug Info IC50 = 83 nM
NP-118809 Drug Info IC50 = 110 nM [530438]
Nifedipine Drug Info Ki = 470 nM [552597]
PD-144550 Drug Info IC50 = 620 nM
3-(aminomethyl)-4-(thiophen-3-yl)butanoic acid Drug Info IC50 = 832 nM [527684]
Trans-dimethyl gababutin Drug Info IC50 = 22 nM [530573]
4-(3-bromobenzylthio)-2-aminobutanoic acid Drug Info Ki = 31 nM [527946]
2-amino-2-(2-fluorophenyl)acetic acid Drug Info Ki = 260 nM [527946]
2-amino-2-(2,4-difluorophenyl)acetic acid Drug Info Ki = 3500 nM [527946]
4-(2-bromobenzylthio)-2-aminobutanoic acid Drug Info Ki = 20 nM [527946]
4-(2,5-dichlorobenzylthio)-2-aminobutanoic acid Drug Info Ki = 21 nM [527946]
2-amino-2-(3-chloro-4-fluorophenyl)acetic acid Drug Info Ki = 310 nM [527946]
2-amino-4-(2-methyl-benzylsulfanyl)-butyric acid Drug Info Ki = 7.6 nM [527946]
4-(4-chlorobenzylthio)-2-aminobutanoic acid Drug Info Ki = 4.3 nM [527946]
(S)-2-amino-2-phenylpropanoic acid Drug Info Ki = 170 nM [527946]
(S)-2-amino-3-(benzylthio)propanoic acid Drug Info Ki = 110 nM [527946]
4-(2-methoxybenzylthio)-2-aminobutanoic acid Drug Info Ki = 1500 nM [527946]
4-(3,4-dimethylbenzylthio)-2-aminobutanoic acid Drug Info Ki = 66 nM [527946]
4-(2-cyanobenzylthio)-2-aminobutanoic acid Drug Info Ki = 760 nM [527946]
4-(2-nitrobenzylthio)-2-aminobutanoic acid Drug Info Ki = 1300 nM [527946]
(S)-2-amino-2-cyclohexylacetic acid Drug Info Ki = 60 nM [527946]
4-(3,5-dichlorobenzylthio)-2-aminobutanoic acid Drug Info Ki = 19 nM [527946]
4-(3-methoxybenzylthio)-2-aminobutanoic acid Drug Info Ki = 510 nM [527946]
(S)-phenylglycine Drug Info Ki = 180 nM [527946]
2-amino-2-(2,3-difluorophenyl)acetic acid Drug Info Ki = 96 nM [527946]
(S)-2-amino-4-(benzylthio)butanoic acid Drug Info Ki = 28 nM [527946]
Rac-2-amino-5-cyclohexylpentanoic acid Drug Info Ki = 60 nM [527946]
2-amino-2-(3-bromophenyl)acetic acid Drug Info Ki = 39 nM [527946]
4-(3-nitrobenzylthio)-2-aminobutanoic acid Drug Info Ki = 39 nM [527946]
4-(3-cyanobenzylthio)-2-aminobutanoic acid Drug Info Ki = 840 nM [527946]
2-amino-2-(3-chlorophenyl)acetic acid Drug Info Ki = 54 nM [527946]
ETHIONINE Drug Info Ki = 100 nM [527946]
3-(aminomethyl)-4-(furan-2-yl)butanoic acid Drug Info IC50 = 421 nM [527684]
4-(3,5-dimethylbenzylthio)-2-aminobutanoic acid Drug Info Ki = 450 nM [527946]
(S)-2-amino-3-cyclohexylpropanoic acid Drug Info Ki = 90 nM [527946]
4-(4-tert-butylbenzylthio)-2-aminobutanoic acid Drug Info Ki = 79 nM [527946]
1-benzhydryl-4-(4,4-diphenylbutyl)piperazine Drug Info IC50 = 6000 nM [530438]
4-(3-fluorobenzylthio)-2-aminobutanoic acid Drug Info Ki = 19 nM [527946]
(S)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid Drug Info IC50 = 178 nM [527684]
4-(2,3-dichlorobenzylthio)-2-aminobutanoic acid Drug Info Ki = 5.3 nM [527946]
3-(aminomethyl)-4-(thiophen-2-yl)butanoic acid Drug Info IC50 = 2140 nM [527684]
Rac-2-amino-4-phenylbutanoic acid Drug Info Ki = 5400 nM [527946]
4-(3-chlorobenzylthio)-2-aminobutanoic acid Drug Info Ki = 26 nM [527946]
4-(4-bromobenzylthio)-2-aminobutanoic acid Drug Info Ki = 4.5 nM [527946]
4-(3,4-dichlorobenzylthio)-2-aminobutanoic acid Drug Info Ki = 3.7 nM [527946]
2-amino-2-(thiophen-2-yl)acetic acid Drug Info Ki = 210 nM [527946]
References
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 530504Bioorg Med Chem Lett. 2010 Jan 1;20(1):362-5. Epub 2009 Oct 25.Synthesis and in vivo evaluation of 3-substituted gababutins.
Ref 530504Bioorg Med Chem Lett. 2010 Jan 1;20(1):362-5. Epub 2009 Oct 25.Synthesis and in vivo evaluation of 3-substituted gababutins.
Ref 527016Bioorg Med Chem Lett. 2004 Apr 19;14(8):1913-6.N-Acridin-9-yl-butane-1,4-diamine derivatives: high-affinity ligands of the alpha2delta subunit of voltage gated calcium channels.
Ref 530438Bioorg Med Chem Lett. 2009 Nov 15;19(22):6467-72. Epub 2009 Sep 11.Scaffold-based design and synthesis of potent N-type calcium channel blockers.
Ref 530438Bioorg Med Chem Lett. 2009 Nov 15;19(22):6467-72. Epub 2009 Sep 11.Scaffold-based design and synthesis of potent N-type calcium channel blockers.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527684Bioorg Med Chem Lett. 2006 May 1;16(9):2329-32. Epub 2005 Aug 15.Heteroaromatic side-chain analogs of pregabalin.
Ref 527684Bioorg Med Chem Lett. 2006 May 1;16(9):2329-32. Epub 2005 Aug 15.Heteroaromatic side-chain analogs of pregabalin.
Ref 530504Bioorg Med Chem Lett. 2010 Jan 1;20(1):362-5. Epub 2009 Oct 25.Synthesis and in vivo evaluation of 3-substituted gababutins.
Ref 530438Bioorg Med Chem Lett. 2009 Nov 15;19(22):6467-72. Epub 2009 Sep 11.Scaffold-based design and synthesis of potent N-type calcium channel blockers.
Ref 552597Development and validation of an in silico P450 profiler based on pharmacophore models. Curr Drug Discov Technol. 2006 Mar;3(1):1-48.
Ref 527684Bioorg Med Chem Lett. 2006 May 1;16(9):2329-32. Epub 2005 Aug 15.Heteroaromatic side-chain analogs of pregabalin.
Ref 530573Bioorg Med Chem Lett. 2010 Jan 15;20(2):461-4. Epub 2009 Nov 27.Synthesis and in vivo evaluation of bicyclic gababutins.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527684Bioorg Med Chem Lett. 2006 May 1;16(9):2329-32. Epub 2005 Aug 15.Heteroaromatic side-chain analogs of pregabalin.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 530438Bioorg Med Chem Lett. 2009 Nov 15;19(22):6467-72. Epub 2009 Sep 11.Scaffold-based design and synthesis of potent N-type calcium channel blockers.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527684Bioorg Med Chem Lett. 2006 May 1;16(9):2329-32. Epub 2005 Aug 15.Heteroaromatic side-chain analogs of pregabalin.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527684Bioorg Med Chem Lett. 2006 May 1;16(9):2329-32. Epub 2005 Aug 15.Heteroaromatic side-chain analogs of pregabalin.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
Ref 527946Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. Epub 2005 Dec 27.Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.